Weekly Digest 5/1/20
Happy Friday, May 1!
Hope you all had a great Week 4! Please find below our SWS-curated round-up of interesting articles, resources, information, and opportunities related to COVID-19’s impact on real world finance that may be useful to you!
This Article from the WSJ unpacks the notion of social distancing as ‘a new economic indicator’. Just as GDP tries to capture the vast diversity of economic activity in a single number measuring national output, modelers and statisticians are looking to synthesize a large array of data for social distancing indicators to understand economic activity.
This is a great read to summarize the position of different states as a number start to reopen.
As the current leader in confirmed COVID19 cases, the U.S. is expected to account for 31% of this year’s decline in worldwide gross domestic product, according to Bloomberg. Though the U.S. and global economy has taken a hard hit, this article touches on the growth expected to rebound as of 2021.
“The rising economic toll of pandemic-induced shutdowns is fueling suspicions that government leaders are listening too much to epidemiologists and not enough to economists.“ As the pandemic continues to fuel a ‘stand off’, so to speak, between epidemiologists and economists, this WSJ read unpacks how and why policy responses must balance input from both disciplines.
The Food and Drug Administration granted an emergency-use authorization for a new antiviral drug, cleared for emergency use for covid19 patients. This drug, ‘Remdisivir’ has become the first medication backed by early clinical data made available to fight the novel coronavirus. Read more here!
Enjoy the weekend!
Cheers,
The SWS Exec Team